Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir …
J Fokam, E Ngoufack Jagni Semengue… - Microbiology …, 2022 - Am Soc Microbiol
To ensure the long-term efficacy of dolutegravir (DTG), we evaluated the genotypic profile in
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
Evaluation of circulating and archived HIV-1 integrase drug-resistance variants among patients on third-line ART in Cameroon: implications for dolutegravir-containing …
J Fokam, ENJ Semengue, E Molimbou, NK Etame… - 2022 - cabidigitallibrary.org
To ensure the long-term efficacy of dolutegravir (DTG), we evaluated the genotypic profile in
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir …
J Fokam, E Ngoufack Jagni Semengue… - MICROBIOLOGY …, 2022 - art.torvergata.it
We described the analysis of the genotypes of the population within third-line antiviral
therapy in Cameroon, with a focus on defining the effects of prior raltegravir (RAL) treatment …
therapy in Cameroon, with a focus on defining the effects of prior raltegravir (RAL) treatment …
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir …
J Fokam, ENJ Semengue, E Molimbou, NK Etame… - 2022 - agris.fao.org
To ensure the long-term efficacy of dolutegravir (DTG), we evaluated the genotypic profile in
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
[HTML][HTML] Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for …
J Fokam, ENJ Semengue, E Molimbou… - Microbiology …, 2022 - ncbi.nlm.nih.gov
To ensure the long-term efficacy of dolutegravir (DTG), we evaluated the genotypic profile in
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir …
J Fokam, E Molimbou, NK Etame, MM Santoro… - Microbiology …, 2022 - europepmc.org
To ensure the long-term efficacy of dolutegravir (DTG), we evaluated the genotypic profile in
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir …
J Fokam, ENJ Semengue, E Molimbou… - Microbiology …, 2022 - pubmed.ncbi.nlm.nih.gov
To ensure the long-term efficacy of dolutegravir (DTG), we evaluated the genotypic profile in
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …
viral reservoirs among patients on third-line (3L) antiretroviral therapy (ART) in Cameroon …